Learn how targeting the IgG Fc region preserves Fab binding affinity, avoids steric hindrance, and optimizes IVD immunoassay performance.
Discover essential functional (CH50, AH50) and quantitative (C3, C4, C1q, C5) targets for developing robust complement evaluation IVD kits.
Discover essential cytokine targets (IL-6, IFN-γ, IL-10) for CRS IVD kits, raw material selection criteria, and multiplex assay trade-offs.
Discover essential biomarkers (IgG, CD19/20/30/52) and key raw material components for developing robust immunodeficiency IVD assay panels.
Explore how targeted mAb therapies shape cell target selection, panel design, and monoclonal antibody raw material choices in flow cytometry IVD assays.
Explore why functional complement testing outperforms C5 total antigen assays in monitoring C5 mAb therapies for IVD assay developers.
Discover the essential reagent, buffer, technical, and calibration requirements for developing accurate clinical Flow-FISH telomere assays.
Learn how combining immunoserology and functional flow cytometry enables accurate IVD detection of immunodeficiency phenocopies.
Learn the two-tier diagnostic workflow for complement deficiencies and how CH50/AH50 and quantitative immunoassays shape IVD kit development.
Discover how autoantibody-mediated phenocopies of PID are diagnosed using a two-tiered strategy (ELISA, flow cytometry) and essential IVD reagents.
Learn how Flow-FISH measures telomere length to diagnose short telomere syndromes, along with key technical considerations for IVD reagent development.
Learn why transcript-based ISG panels (6-gene & 28-gene) replace direct cytokine testing for assessing Type I interferon activity in diagnostics.
Explore key biomarkers for ALPS multiplex IVD panels: DNT cells, sFasL, IL-10, IL-18, Vitamin B12, and Tregs for accurate differential diagnosis.
Learn which TLR agonists (MyD88 & TRIF pathways) to select for functional cell-based immunoassay panels to diagnose innate immunodeficiencies.
Discover why intracellular flow cytometry beats sequencing for NCF1 deficiency diagnostics by bypassing pseudogenes for fast, clear results.
Learn how sample quality affects DHR 123 flow cytometry assays and discover key controls for accurate neutrophil function testing.
Learn key cell surface (TCRαβ, DNT, B220) and soluble biomarkers (sFasL, IL-10, IL-18) for designing clinically validated ALPS IVD panels.
Master flow cytometry panel design using CD14+ monocytes to detect intracellular Btk in XLA when B cells are absent. Insights for IVD developers.
Learn flow cytometry biomarker strategies using pATM and γH2AX to assess DNA DSB repair defects, including reagent optimization & assay controls.
Learn how TREC serves as a SCID biomarker and discover key design considerations for high-sensitivity TREC qPCR diagnostic kits.
Learn how FcRn regulates IgG serum half-life through pH-dependent recycling and why its dynamics matter for IVD calibrators and antibody design.
Master T-cell subsetting in flow cytometry. Learn how combining CD45RA, CD45RO, CCR7, and CD31 avoids TEMRA misclassification in IVD panels.
Learn the essential diagnostic platforms and high-purity reagent standards required for accurate CVID evaluation, functional assays, and subtyping.
Learn the essential molecular components, qPCR master mixes, and quantitative reference standards needed for accurate TREC SCID newborn screening.
Learn why total IgG masks subclass deficiencies and discover the raw materials—monoclonals & calibrators—needed for accurate IVD assay development.
Learn why purified Bos d 8 casein raw materials are essential in CRD allergy diagnostic kits to eliminate cross-reactivity and boost specificity.
Learn how IgE and IgG physiological half-lives guide raw material selection, calibrator stability, and dynamic range in IVD immunoassay design.
Learn the essential biomarker panel—C4, C1-INH antigen/function, C1q, and tryptase—to accurately differentiate HAE from IgE-mediated angioedema.
Learn how raw material choices differ for Allergic Rhinitis (IgE capture) and Autoimmune Chronic Urticaria (IgG autoantibody capture) immunoassays.
Discover critical food allergen targets, inflammatory markers, and mRNA biomarkers for building high-performance EoE IVD diagnostic panels.
Learn why alpha-gal carbohydrate antigens are essential for IVD diagnostic tests targeting delayed red meat allergy and pre-biologic safety screening.
Discover key recombinant allergens (Amb a 1, Art v 1, Art v 6) to eliminate cross-reactivity and build precise ragweed vs. mugwort IVD assays.
Discover how recombinant Cyn d 1, Phl p 1, and Phl p 5 allow precise component-resolved differentiation of Bermuda vs. Timothy grass allergies.
Learn how purified recombinant Bet v 1 improves CRD immunoassay specificity, resolves cross-reactivity, and optimizes tree pollen allergy kits.
Learn why Golden hamster extracts cause false negatives in allergy kits and how recombinant lipocalins & rMes a 1 improve IVD diagnostic accuracy.
Discover why Mus m 1 and Rat n 1.02 are essential IVD raw materials for laboratory animal allergy (LAA) assays and occupational diagnostic panels.
Discover why recombinant Bet v 1 is the key foundational raw material for Fagales tree pollen IgE assay design and batch-to-batch consistency.
Learn how Phl p 1, Phl p 5, and Cyn d 1 resolve grass pollen cross-reactivity in CRD assays to differentiate temperate and Bermuda grass allergies.
Learn key technical & standardization requirements for sourcing un-ammoniated latex C-serum raw materials for accurate IgE assays.
Discover key raw material strategies for Can f 5 in dog allergy diagnostic panels to eliminate false negatives and improve assay sensitivity.
Master IVD formulation for rodent allergy diagnostics. Learn to overcome Mus m 1, Rat n 1, and Equ c 1 cross-reactivity with recombinant allergens.
Discover why differentiating Fel d 1 and Fel d 2 raw materials is critical to prevent cross-reactivity and optimize cat allergy CRD assays.
Learn why CRD egg allergy panels require both Gal d 1 and Gal d 2 raw materials to accurately differentiate baked egg tolerance and allergy severity.
Learn how the heat-stability of Bos d 8 vs. Bos d 4 & 5 guides raw material selection for precise milk allergy diagnostic kit development.
Learn why incorporating Ara h 2 and Ara h 8 into peanut CRD panels eliminates false positives and enables precise allergy risk stratification.
Learn essential bio-functional raw materials and detection mechanisms (SPR & electrochemical) for developing sensitive food allergen biosensors.
Learn how Casein and Whey epitope structures influence IVD raw material selection to improve cow's milk allergy diagnostic accuracy.
Discover how standardized allergen raw materials eliminate cross-reactivity and ensure high diagnostic precision in CRD immunoassay microarrays.
Learn the essential raw materials for BAT assay development, including CD63/CD203c markers, IL-3 priming agent, standardized allergens, and buffers.
Learn how Eosinophil Cationic Protein (ECP) is evaluated in sandwich immunoassays and explore key considerations for developing robust ECP kits.
Explore the core causes of sIgE immunoassay divergence—allergen quality, matrix chemistry, and calibration—and how to optimize IVD assay design.
Explore key differences between total IgE and allergen-specific IgE (sIgE) assays and how they dictate IVD raw material requirements.
Learn how Th1/Th2 immune polarization guides marker selection in multiplex immunoassays, covering IFN-γ, IL-4, IL-5, and IL-13.
Discover how IgE structural properties and extreme scarcity guide raw material selection for reliable allergy diagnostic immunoassays.
Learn how therapeutic monoclonal antibodies interfere with IFE and crossmatching, and discover key mitigation strategies for IVD developers.
Master therapeutic mAb quantification by LC-MS/MS. Discover key workflows, critical raw materials, SIL peptides, and assay optimization tips.
Discover why cell-based reporter gene assays are the recommended standard for detecting functional NAbs in mAb clinical diagnostic development.
Learn how ECLIA detects anti-drug antibodies (ADA) using bridging assays and explore key IVD raw materials needed for robust assay development.
Compare Th1 and Th2 cytokine profiles (IFN-γ vs IL-4, IL-5, IL-13) and discover key strategies for developing accurate allergy diagnostic assays.
Discover why therapeutic mAbs cause immunoassay interference and how diagnostic developers can use anti-idiotype antibodies and mass spec to fix it.
Learn how ECL bridging immunoassays detect anti-drug antibodies (ADA) and explore critical raw materials for high-sensitivity assay development.
Learn essential sample preparation strategies and raw material requirements for developing robust mAb TDM LC-MS/MS assays from concept to clinic.
Learn how Fab-arm exchange causes bridging ELISAs to miss IgG4 ADAs and how to adapt your assay design using liquid-phase platforms.
Learn what causes drug interference in ADA immunoassay development and how acid dissociation & trough sampling eliminate false negatives.
Learn how drug interference causes false-negative ADA assay results and explore strategies like acid dissociation, HMSA, and ECLIA for drug tolerance.
Learn how to solve biosimilar ADA assay challenges with matched antigens, optimized blocking buffers, and rigorous comparability validation.
Learn how FcRn recycling and mAb pharmacokinetics shape IVD raw material selection for TDM assays, ensuring high specificity and affinity.
Discover how mAb formats impact immunogenicity and learn best practices for designing robust ADA bridging assays with high-affinity reagents.
Learn how internal validation and high-specificity IVD raw materials prevent matrix interference and lot variability in TDM and ADA assays.
Compare mixed, PRA, and single-antigen beads in raw material choice, assay design, and specificity for anti-HLA antibody detection.
Explore the immunological cause of TRALI and key raw materials like recombinant HLA, HNA, and HPA needed to develop donor screening kits.
Learn how therapeutic mAbs cause interference in cell-based compatibility testing and explore effective mitigation strategies for assay developers.
Discover why IgG is the top target in IVD assay development, its biochemical strengths, Fc interference trade-offs, and design tips.
Learn how HLA Class I and II expression differences affect antigen selection for organ transplant crossmatching and platelet transfusion assays.
Learn why pre-transplant CMV screening is vital in HCT and how high-purity IVD raw materials ensure accurate serology assay development.
Explore why quantitative PCR is vital for post-transplant CMV and EBV monitoring and how diagnostic kit design ensures reliable clinical decisions.
Discover essential biomarkers like Galactomannan and β-D-glucan for developing IVD assays to detect fungal infections in transplant patients.
Explore core aGVHD biomarkers (REG3a, Elafin, HGF) for immunoassay development, from target selection to IVD raw material optimization.
Learn the key hallmarks of active AMR in renal allografts and how distinguishing them from TCMR drives precise transplant rejection IVD assay design.
Discover key non-HLA transplant screening parameters (DSA, CMV, ABO) and how high-purity IVD raw materials power accurate donor diagnostic assays.
Learn why HLA-DPB1 immunogenic categorization prevents GVHD in transplant selection and discover essential raw materials for high-res IVD assays.
Learn the differences between serological & molecular HLA typing in transplantation, plus key IVD raw material choices for accurate assay design.
Discover how C4d IF reagents aid renal AMR diagnosis and key criteria assay developers need to optimize sensitivity and specificity.
Explore key biomarkers for organ graft monitoring (creatinine, ALT/AST, C-peptide) and best practices for developing precise, stable IVD assays.
Discover why CMV, BKPyV, and EBV are critical viral targets for post-transplant PCR assay development, plus key design and optimization strategies.
Learn why quantitative PCR for BK virus and EBV is vital in post-transplant care and how to optimize IVD molecular diagnostic kit development.
Discover key cell surface markers (CD25, CD52, CD20, CD3) in transplant induction therapies and how to select raw mAbs for flow cytometry assays.
Learn why TDM is vital for tacrolimus & cyclosporine, and explore essential IVD assay requirements for high specificity and accuracy.
Explore key T-cell signaling pathways (CD3, CD28, IL-2) & cytokines (IFN-γ, IL-6) for developing high-performance transplant immunology IVD kits.
Learn how calcineurin inhibitor mechanics and clinical needs guide IVD TDM assay development, antibody selection, and matrix-release solutions.
Explore key autoantigens like Jo-1, Sm, and HMGCR for multiplex panels to differentiate myositis, SLE overlap, and autoimmune muscle diseases.
Learn key autoantigens (PR3, MPO) and IIF patterns (cANCA, pANCA) essential for designing highly specific GPA diagnostic immunoassay panels.
Discover which organ perfusion viability markers (cytokines, injury proteins, metabolic readouts) need dedicated diagnostic raw materials.
Discover key reagent specs for FCX assays: F(ab')₂ fragments, heavy-chain specificity, and blocking buffers to differentiate anti-HLA IgG/IgM.
Learn how ABOi transplant monitoring drives isoagglutinin kit design through antigen selection, IgG/IgM specificity, and matrix control.
Learn why including non-HLA targets like MICA, AT1R, and vimentin in IVD assays prevents graft rejection and closes diagnostic blind spots.
Discover why the α3(IV)NC1 domain of type IV collagen is the essential antigen for developing high-sensitivity anti-GBM diagnostic assays.
Learn how incorporating anti-Domain 1 IgG and aPS/PT into APS immunoassay panels resolves seronegative cases and sharpens thrombotic risk.
Discover how ethanol vs. formalin fixation impacts ANCA assay accuracy and how dual-substrate systems eliminate false pANCA from ANA interference.
Learn how combining IgG-specific detection with dual aCL and anti-β2GPI targets optimizes IVD assay sensitivity, specificity, and diagnostic yield.